Related Experiment Video
Updated: Sep 21, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Maternal type 1 diabetes, pre-term birth and risk of autism spectrum disorder-a prospective cohort study
Martina Persson1,2,3, Abraham Reichenberg2,3, Mikael Andersson Franko1,4
1Department of Clinical Science and Education, Division of Pediatrics, Karolinska Institutet, Stockholm, Sweden.
Insights
Maternal type 1 diabetes (T1D) is linked to a higher risk of autism spectrum disorder (ASD) in children. Pre-term birth accounts for a significant portion of this increased risk, while HbA1c levels did not show an independent association.
Area of Science:
- Reproductive Health
- Pediatric Neurology
- Endocrinology
Background:
- Maternal type 1 diabetes (T1D) is a known risk factor for adverse pregnancy outcomes.
- The association between maternal T1D and autism spectrum disorder (ASD) in offspring requires further investigation.
- The mediating role of pre-term birth and the impact of maternal glycated haemoglobin (HbA1c) levels remain unclear.
Purpose of the Study:
- To investigate the association between maternal T1D and ASD risk in offspring.
- To determine the extent to which pre-term birth mediates this association.
- To assess the impact of maternal HbA1c levels on ASD risk in offspring of mothers with T1D.
Main Methods:
- A large-scale cohort study of 1.4 million Swedish children born between 1998 and 2015.
- Utilized national registers to obtain data on maternal T1D, HbA1c, pre-term birth, and offspring ASD diagnoses.
- Employed Cox regression and log-binomial regression to estimate relative risks (RR) and hazard ratios (HR).
Main Results:
- Offspring of mothers with T1D had an increased risk of ASD (HR = 1.40).
- Pre-term birth mediated approximately 22% of the T1D-associated ASD risk (RR = 1.06).
- Maternal HbA1c levels were not independently associated with ASD risk beyond the T1D diagnosis itself.
Conclusions:
- Maternal T1D is associated with an elevated risk of ASD in offspring.
- Pre-term birth is a significant contributing factor to the increased ASD risk in this population.
- Clinical awareness and management of T1D pregnancies should consider the heightened risk of ASD, particularly when pre-term birth is a concern.
Background:
It has been suggested that maternal type 1 diabetes (T1D) increases the risk of autism spectrum disorder (ASD) in the offspring. However, it is unclear whether this risk is mediated by pre-term birth, affecting around one-third of pregnancies with T1D, and whether maternal levels of glycated haemoglobin (HbA1c) impact the risk.
Methods:
A cohort of 1.4 million Swedish children born between 1998 and 2015, and their parents. Maternal T1D and HbA1c before or in early pregnancy, gestational and ASD diagnoses were obtained from Swedish national registers. Relative risk (RR) and 95% CIs of ASD were estimated by hazard ratios (HRs) from Cox regression or RR from log-binomial regression.
Results:
Of 1 406 650 children, 8003 (0.6%) were born to mothers with T1D, 24 941 (1.8%) were diagnosed with ASD and 81 915 (5.8%) were born pre-term. The risk of ASD was increased in offspring of mothers with T1D was HR = 1.40 (1.21-1.61). The RR for each +5-mmol/mol excess HbA1c was estimated at HR = 1.03 (0.97-1.10). The T1D effect on ASD mediated through pre-term birth was estimated at RR = 1.06 (1.05 to 1.08), corresponding to 22% (16% to 41%) of the total effect. T1D in pregnancy was associated with increased ASD risk in the offspring. Twenty percent of the total effect was accounted for by pre-term birth. HbA1c was not associated with ASD risk, beyond the risk associated by the T1D diagnosis itself.
Conclusion:
Awareness of ASD in the offspring of mothers with T1D may be warranted, especially considering the additional effect of pre-term birth.
More Related Videos
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....